EuropaBio’s launch meeting for Biotech Week will share how science finds its way to an end use, whether it is a new medicine, or a product developed using new scientific processes.
Europe sets the global standard for consumer and environmental protection. This translates into a regulatory framework for different sectors through which novel products must pass before they can be used in Europe. The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) are the gateway for new products and play a critical role in how Europe innovates safely.
It can be complicated, particularly for new science. So how does Europe deliver innovation to benefit patients and our planet whilst ensuring the high standards and safety that we expect?
The Covid response from regulators demonstrated how Europe can be agile and rapid for the vaccines that are now helping Europe restore a safe and open society. Our launch event for Biotech Week brings together the community that develops products from science to consumers, highlighting how we can evolve our regulatory systems help develop safe societies and a competitive Europe.
Confirmed speakers:
Join us to find out how science reaches its target and help EuropaBio kick start a week dedicated to the explanation and celebration of biotechnology.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.